610 related articles for article (PubMed ID: 19140076)
1. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
[TBL] [Abstract][Full Text] [Related]
2. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
[TBL] [Abstract][Full Text] [Related]
4. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
Rosa AR; Cruz N; Franco C; Haro JM; Bertsch J; Reed C; Aarre TF; Sanchez-Moreno J; Vieta E
J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
Wolfsperger M; Greil W; Rössler W; Grohmann R
J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
8. Functional impairment in patients with mania: baseline results of the EMBLEM study.
Goetz I; Tohen M; Reed C; Lorenzo M; Vieta E;
Bipolar Disord; 2007; 9(1-2):45-52. PubMed ID: 17391349
[TBL] [Abstract][Full Text] [Related]
9. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
Bellantuono C; Barraco A; Rossi A; Goetz I
BMC Psychiatry; 2007 Jul; 7():33. PubMed ID: 17640381
[TBL] [Abstract][Full Text] [Related]
10. Voluntary vs. involuntary hospital admission in acute mania of bipolar disorder: results from the Swiss sample of the EMBLEM study.
Schuepbach D; Goetz I; Boeker H; Hell D
J Affect Disord; 2006 Jan; 90(1):57-61. PubMed ID: 16324749
[TBL] [Abstract][Full Text] [Related]
11. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
Reed C; Novick D; Gonzalez-Pinto A; Bertsch J; Haro JM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):715-21. PubMed ID: 19345251
[TBL] [Abstract][Full Text] [Related]
12. [Management of patients with acute manic or mixed episodes and outcome at three months].
Azorin JM; Luquiens A; Aubrun E; Reed C; Gasquet I; Lukasiewicz M
Encephale; 2010 Jun; 36(3):226-35. PubMed ID: 20620265
[TBL] [Abstract][Full Text] [Related]
13. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
Cruz N; Vieta E; Comes M; Haro JM; Reed C; Bertsch J;
J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with pharmacologic noncompliance in patients with mania.
Keck PE; McElroy SL; Strakowski SM; Stanton SP; Kizer DL; Balistreri TM; Bennett JA; Tugrul KC; West SA
J Clin Psychiatry; 1996 Jul; 57(7):292-7. PubMed ID: 8666570
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
[TBL] [Abstract][Full Text] [Related]
16. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM).
Van Riel WG; Vieta E; Martinez-Aran A; Haro JM; Bertsch J; Reed C; Van Os J
World J Biol Psychiatry; 2008; 9(4):313-20. PubMed ID: 18949649
[TBL] [Abstract][Full Text] [Related]
17. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.
Craig TJ; Grossman S; Mojtabai R; Gibson PJ; Lavelle J; Carlson GA; Bromet EJ
Bipolar Disord; 2004 Oct; 6(5):406-15. PubMed ID: 15383133
[TBL] [Abstract][Full Text] [Related]
18. Determinants of voluntary vs. involuntary admission in bipolar disorder and the impact of adherence.
Schuepbach D; Novick D; Haro JM; Reed C; Boeker H; Noda S; Angst J; Hell D;
Pharmacopsychiatry; 2008 Jan; 41(1):29-36. PubMed ID: 18203049
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy in bipolar disorder].
Nolen WA
Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1299-305. PubMed ID: 10416483
[TBL] [Abstract][Full Text] [Related]
20. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM).
Bellivier F; Yon L; Luquiens A; Azorin JM; Bertsch J; Gerard S; Reed C; Lukasiewicz M
Bipolar Disord; 2011 Jun; 13(4):377-86. PubMed ID: 21843277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
